ALEC — Alector, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1653087 ·
Last close
$2.19
Market Cap
$243.15M
52W High
$2.74
52W Low
$1.89
ADV30
552,977
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,046,000 | — | -24,919,000 | -22,930,000 | 239,916,000 | 76,962,000 | 229,534,000 |
| Dec 2025 | 6,237,000 | — | -39,566,000 | -37,267,000 | 293,237,000 | 65,802,000 | 262,588,000 |
| Sep 2025 | 3,260,000 | — | -37,608,000 | -34,667,000 | 335,285,000 | 76,503,000 | 277,573,000 |
| Jun 2025 | 7,874,000 | — | -34,138,000 | -30,524,000 | 356,422,000 | 44,771,000 | 285,247,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-184,031,000
Investing CF
$196,597,000
Financing CF
$20,215,000
CapEx
$-214,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.39
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-972,056,000
Inventory
—
Receivables
—
ST Investments
$190,222,000
EBIT TTM
$-156,007,000
Pretax Income TTM
$-142,761,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$18,417,000
EBITDA
$-127,494,000
Free Cash Flow
$-119,106,128
Enterprise Value
$73,398,664
Total Cash
$206,515,008
Total Debt
$34,548,000
Shares Out
111,025,187
Trailing EPS
$-1.18
Book Value
$0.09
ROE
-238.9%
ROA
-25.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 21,045,000 | -156,007,000 | -142,929,000 | 293,237,000 | 262,588,000 | — | -184,031,000 |
| Dec 2024 | 100,558,000 | -144,997,000 | -119,049,000 | 468,303,000 | 341,503,000 | — | -229,905,000 |
| Dec 2023 | 97,062,000 | -151,740,000 | -130,391,000 | 621,827,000 | 487,669,000 | — | -184,162,000 |
| Dec 2022 | 133,617,000 | -137,834,000 | -133,310,000 | 787,648,000 | 573,206,000 | — | -20,329,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.70
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | $243.00M | $7.75 | — |
| HUMA | Humacyte, Inc. | $246.44M | $1.11 | — |
| FATE | FATE THERAPEUTICS INC | $250.60M | $2.15 | — |
| CGEN | COMPUGEN LTD | $250.65M | $2.65 | — |
| AVXL | ANAVEX LIFE SCIENCES CORP. | $251.14M | $2.71 | — |
News headlines (Yahoo Finance, 1h cache)
How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus
2026-05-19 04:34 · Yahoo
Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates
2026-05-07 23:05 · Yahoo
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-07 20:05 · Yahoo
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
2026-05-07 14:00 · Yahoo
Alkermes (ALKS) Reports Q1 Loss, Beats Revenue Estimates
2026-05-05 12:25 · Yahoo
GSK Juggles Alzheimer’s Setback And Leadership Shift With Product Progress
2026-05-03 01:19 · Yahoo
How The Alector (ALEC) Narrative Is Shifting Toward BBB Shuttle Programs And Execution Risk
2026-04-30 12:08 · Yahoo
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis
2026-04-29 20:05 · Yahoo
Discovering Middle East's Undiscovered Gems This April 2026
2026-04-28 03:33 · Yahoo
Undiscovered Gems in the Middle East for March 2026
2026-03-26 08:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.